GB0701262D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0701262D0
GB0701262D0 GB0701262A GB0701262A GB0701262D0 GB 0701262 D0 GB0701262 D0 GB 0701262D0 GB 0701262 A GB0701262 A GB 0701262A GB 0701262 A GB0701262 A GB 0701262A GB 0701262 D0 GB0701262 D0 GB 0701262D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0701262A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0701262A priority Critical patent/GB0701262D0/en
Publication of GB0701262D0 publication Critical patent/GB0701262D0/en
Priority to PCT/EP2008/050290 priority patent/WO2008087102A1/en
Priority to US12/013,011 priority patent/US20080187535A1/en
Priority to TW097101177A priority patent/TWI434697B/en
Priority to EP08701434A priority patent/EP2114993B1/en
Priority to PT08701434T priority patent/PT2114993E/en
Priority to DK08727588.9T priority patent/DK2118128T3/en
Priority to EA200900795A priority patent/EA016326B1/en
Priority to PE2012001372A priority patent/PE20130324A1/en
Priority to AU2008206463A priority patent/AU2008206463B2/en
Priority to BRPI0806463-6A priority patent/BRPI0806463A2/en
Priority to PL08701434T priority patent/PL2114993T3/en
Priority to SI200830787T priority patent/SI2114993T1/en
Priority to CN2008800078884A priority patent/CN101668770B/en
Priority to ARP080100128A priority patent/AR064863A1/en
Priority to KR1020097017027A priority patent/KR20090101313A/en
Priority to CA002674552A priority patent/CA2674552A1/en
Priority to DK08701434.6T priority patent/DK2114993T3/en
Priority to AU2008207025A priority patent/AU2008207025B2/en
Priority to MX2009007571A priority patent/MX2009007571A/en
Priority to JP2009545186A priority patent/JP5391080B2/en
Priority to PE2008000124A priority patent/PE20081686A1/en
Priority to NZ578285A priority patent/NZ578285A/en
Priority to ES08701434T priority patent/ES2393812T3/en
Priority to MYPI20092932A priority patent/MY153679A/en
Priority to PT87275889T priority patent/PT2118128E/en
Priority to ARP080100127A priority patent/AR064862A1/en
Priority to JO200815A priority patent/JO2840B1/en
Priority to CL200800104A priority patent/CL2008000104A1/en
Priority to CL200800103A priority patent/CL2008000103A1/en
Priority to DO2009000167A priority patent/DOP2009000167A/en
Priority to IL199663A priority patent/IL199663A0/en
Priority to MA32087A priority patent/MA31093B1/en
Priority to ZA2009/04923A priority patent/ZA200904923B/en
Priority to CO09073705A priority patent/CO6210757A2/en
Priority to CR10971A priority patent/CR10971A/en
Priority to HK10104329.2A priority patent/HK1138853A1/en
Priority to HRP20120828AT priority patent/HRP20120828T1/en
Priority to CY20121101065T priority patent/CY1113760T1/en
Ceased legal-status Critical Current

Links

GB0701262A 2007-01-15 2007-01-23 Vaccine Ceased GB0701262D0 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
GB0701262A GB0701262D0 (en) 2007-01-23 2007-01-23 Vaccine
MX2009007571A MX2009007571A (en) 2007-01-15 2008-01-11 Vaccine.
AU2008207025A AU2008207025B2 (en) 2007-01-15 2008-01-11 Vaccine
ARP080100127A AR064862A1 (en) 2007-01-15 2008-01-11 FUSION PROTEINS THAT INCLUDE AN ANTIGEN OF TUMOR REJECTION PRAME (DAGE)
TW097101177A TWI434697B (en) 2007-01-15 2008-01-11 Vaccine
EP08701434A EP2114993B1 (en) 2007-01-15 2008-01-11 Vaccine
PT08701434T PT2114993E (en) 2007-01-15 2008-01-11 Vaccine
DK08727588.9T DK2118128T3 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens NY-ESO-1 and LAGE-1
EA200900795A EA016326B1 (en) 2007-01-15 2008-01-11 Vaccine
PE2012001372A PE20130324A1 (en) 2007-01-15 2008-01-11 FUSION PROTEINS INCLUDING AN ANTIGEN PRAME (DAGE)
AU2008206463A AU2008206463B2 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens NY-ESO-1 and LAGE-1
BRPI0806463-6A BRPI0806463A2 (en) 2007-01-15 2008-01-11 fusion protein, nucleic acid sequence, vector, host cell, vaccine, use of a protein or nucleic acid or vectors, process for producing a fusion protein, and method for treating a cancer patient
PL08701434T PL2114993T3 (en) 2007-01-15 2008-01-11 Vaccine
SI200830787T SI2114993T1 (en) 2007-01-15 2008-01-11 Vaccine
CN2008800078884A CN101668770B (en) 2007-01-15 2008-01-11 Vaccine
PE2008000124A PE20081686A1 (en) 2007-01-15 2008-01-11 FUSION PROTEINS INCLUDING AN ANTIGEN PRAME (DAGE)
KR1020097017027A KR20090101313A (en) 2007-01-15 2008-01-11 Vaccine
US12/013,011 US20080187535A1 (en) 2007-01-15 2008-01-11 Vaccine
DK08701434.6T DK2114993T3 (en) 2007-01-15 2008-01-11 VACCINE
PCT/EP2008/050290 WO2008087102A1 (en) 2007-01-15 2008-01-11 Vaccine
JP2009545186A JP5391080B2 (en) 2007-01-15 2008-01-11 vaccine
CA002674552A CA2674552A1 (en) 2007-01-15 2008-01-11 Vaccine
ARP080100128A AR064863A1 (en) 2007-01-15 2008-01-11 FUSION PROTEIN
NZ578285A NZ578285A (en) 2007-01-15 2008-01-11 Fusion protein comprising a prame linked to a immunological fusion partner protein and additional amino acids at the n terminal end of the fusion partner sequence
ES08701434T ES2393812T3 (en) 2007-01-15 2008-01-11 Vaccine
MYPI20092932A MY153679A (en) 2007-01-15 2008-01-11 Vaccine
PT87275889T PT2118128E (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
JO200815A JO2840B1 (en) 2007-01-15 2008-01-13 Vaccine
CL200800104A CL2008000104A1 (en) 2007-01-15 2008-01-14 FUSION PROTEIN THAT INCLUDES AN ANTIGEN ASSOCIATED TO TUMOR (PRAME) OR AN IMMUNOGENIC FRAGMENT OF HIM AND A PROTEIN D DERIVATIVE; NUCLEOTIDIC SEQUENCE CODING SUCH PROTEIN; VECTOR AND CELL GUEST UNDERSTANDING PROTEIN; VACCINE THAT CO
CL200800103A CL2008000103A1 (en) 2007-01-15 2008-01-14 FUSION PROTEIN THAT INCLUDES ANTIGENS OF TESTICULAR CANCER OR FRAGMENTS OF THE SAME NY-ESO-1 LINKED WITH LAGE-1, WHERE AT LEAST ONE IS TRUNCATED, OR INCLUDES ONE OR MORE EPITOPES OF NY-ESO-1 OR LAGE-1 ; NUCLEIC ACID THAT CODIFIES IT; COMPO
DO2009000167A DOP2009000167A (en) 2007-01-15 2009-07-02 VACCINE
IL199663A IL199663A0 (en) 2007-01-15 2009-07-02 Vaccine
MA32087A MA31093B1 (en) 2007-01-15 2009-07-10 vaccine.
ZA2009/04923A ZA200904923B (en) 2007-01-15 2009-07-14 Vaccine
CO09073705A CO6210757A2 (en) 2007-01-15 2009-07-15 FUSION PROEINA THAT INCLUDES PRAME OR AN IMMUNOGENIC FRAGMENT OF THE SAME
CR10971A CR10971A (en) 2007-01-15 2009-08-07 VACCINE
HK10104329.2A HK1138853A1 (en) 2007-01-15 2010-05-03 Vaccine
HRP20120828AT HRP20120828T1 (en) 2007-01-15 2012-10-15 Vaccine
CY20121101065T CY1113760T1 (en) 2007-01-15 2012-11-09 VACCINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0701262A GB0701262D0 (en) 2007-01-23 2007-01-23 Vaccine

Publications (1)

Publication Number Publication Date
GB0701262D0 true GB0701262D0 (en) 2007-02-28

Family

ID=37846812

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0701262A Ceased GB0701262D0 (en) 2007-01-15 2007-01-23 Vaccine

Country Status (1)

Country Link
GB (1) GB0701262D0 (en)

Similar Documents

Publication Publication Date Title
HK1138853A1 (en) Vaccine
IL201782A0 (en) Vaccine
GB0717911D0 (en) Vaccine
HRP20151124T1 (en) Vaccine
ZA201004303B (en) Vaccine
GB0700135D0 (en) Vaccine
ZA201001029B (en) Vaccines
GB0711858D0 (en) Vaccine
GB0822001D0 (en) Vaccine
GB0810710D0 (en) Vaccine
GB0816284D0 (en) Vaccine
GB0816447D0 (en) Vaccine
GB0710538D0 (en) Vaccine
ZA201003851B (en) Vaccine
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0706825D0 (en) Vaccine
GB0712435D0 (en) Vaccine
GB0725107D0 (en) Vaccine
GB0706540D0 (en) Anti-atheroma vaccine
GB0701262D0 (en) Vaccine
GB0712062D0 (en) Vaccine
GB0708522D0 (en) Vaccine
GB0712420D0 (en) Vaccine
GB0712428D0 (en) Vaccine
GB0724651D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)